US Corporate Board Director Changes SEC Filings — July 30, 2026

USA Board Room Changes

By Gunpowder Editorial ·

34 high priority 34 total filings analysed

Executive Summary

This digest of 34 SEC filings reveals a significant wave of board and leadership changes across US-listed companies, with a clear emphasis on strategic succession planning and the addition of independent directors with deep operational and financial expertise.

Key themes include the appointment of former CEOs and CFOs from major firms (e.g., MGM, Atkore, Affirm) to boards, signaling a focus on operational excellence and capital allocation. Period-over-period data from a subset of companies shows a mixed earnings picture: while MasTec and Steven Madden reported strong revenue growth (23% and 19.1% YoY, respectively), Forrester Research saw a 10.3% revenue decline, and PTC Therapeutics' legacy products continued to erode. Insider activity was limited, but the CEO succession at Stride, Inc. and Cabot Corp. are notable for their orderly transitions. The most critical development is the strategic pivot at BrainStorm Cell Therapeutics, appointing a former FDA official as Executive Chairman to navigate a pivotal Phase 3b trial. Overall, the filings suggest a market focused on refreshing leadership to navigate a complex operating environment, with a mix of growth, transition, and risk.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from July 21, 2026.

Investment Signals (10)

  • MasTec (MTZ)

    Record Q2 revenue of $4.4B (+23% YoY) and record adjusted EPS of $2.22 (+49% YoY), driven by the acquisition of The Superior Group. However, Communications segment EBITDA declined 11.6% YoY and free cash flow was negative at -$59M. [BULLISH/BEARISH MIX]

  • Steven Madden (SHOO) (BULLISH)

    Q2 revenue surged 19.1% YoY to $665.9M, swinging from a net loss to a $27.7M profit. Adjusted gross margins improved 460 bps to 46.5%, but adjusted operating expenses as a % of revenue also increased 190 bps to 39.8%.

  • PTC Therapeutics (PTCT)

    Total revenue doubled to $361M in Q2 2026, driven by new product Sephience ($151M, +21% QoQ). Guidance for full-year product revenue was raised to $850-950M. However, legacy products Translarna (-29.1% YoY) and Emflaza (-32.4% YoY) are in rapid decline. [BULLISH/BEARISH MIX]

  • Forrester Research (FORR) (BEARISH)

    Revenue declined 10.3% YoY to $100.2M, with all three segments (Research, Consulting, Events) contracting. Adjusted net income fell 21.4% YoY. Despite this, client retention improved to 77% from 74%, and the company restarted its buyback program.

  • Preliminary FY2026 revenue grew 4.7% YoY to $2.52B, and net income rose 17.5% to $338.2M. The company announced a CEO succession, with board member Robert Knowling taking over, which could signal a strategic shift. [NEUTRAL/BULLISH]

  • Announced a planned CEO succession with CFO Erica McLaughlin promoted to President and CEO, effective Oct 1, 2026. This orderly transition provides continuity, but the departure of a long-tenured CEO and the search for a new CFO introduces some execution risk.

  • Henry Schein (HSIC) (NEUTRAL)

    Announced a major leadership restructuring, creating a new Leadership Team and transitioning three executives (including the COO) to Senior Advisor roles. This move to simplify operations could unlock value but carries execution risk given the departure of key long-tenured leaders.

  • DXC Technology (DXC) (BULLISH)

    Appointed new Presidents for its core business and Global Infrastructure Services to accelerate its AI-centric strategy. This leadership refresh is a positive signal, but the company's turnaround story remains unproven.

  • BrainStorm Cell Therapeutics (BCLI) (BULLISH)

    Appointed former FDA Associate Commissioner Peter J. Pitts as Executive Chairman, signaling a strategic push to advance its NurOwn ALS therapy through a Special Protocol Assessment. This is a high-risk, high-reward catalyst.

  • Beyond Meat (BYND) (NEUTRAL)

    Appointed a new COO, Brijesh Krishnaswamy, from ofi, and founder Ethan Brown was added to the board. The new COO's operational background could help the company navigate its ongoing turnaround, but the part-time start and low initial salary ($110k) are unusual.

Risk Flags (10)

  • Forrester Research (FORR) [HIGH RISK]

    Revenue declined 10.3% YoY, with all three segments contracting. Contract value fell 3% YoY to $283.2M, signaling a shrinking top-line. Adjusted net income dropped 21.4% YoY.

  • PTC Therapeutics (PTCT) [HIGH RISK]

    Legacy products Translarna (-29.1% YoY) and Emflaza (-32.4% YoY) are in rapid decline due to generic erosion. The company's growth is now heavily dependent on the single product Sephience, creating concentration risk.

  • MasTec (MTZ) [HIGH RISK]

    Free cash flow was negative at -$59M, worsening from -$45M in the prior year. Net debt increased to $2.42B from $1.93B, and cash decreased to $315.6M from $396.0M, indicating significant cash burn from acquisitions and operations.

  • Sirius XM Holdings (SIRI) [MEDIUM RISK]

    The EVP and COO is departing with no successor to be appointed, and the role is being eliminated. This could indicate a lack of strategic direction or a cost-cutting measure that may impact operations.

  • Cyngn Inc. (CYN) [HIGH RISK]

    The VP of Sales was terminated with no successor announced. For a company with no disclosed revenue, the loss of a key sales executive is a significant red flag for its growth prospects.

  • Tennant Company (TNC) [MEDIUM RISK]

    The CFO is retiring, and a search is underway. While the transition is planned, the departure of a key financial leader who oversaw growth strategy and M&A introduces leadership transition risk, especially with a replacement not expected until Q1 2027.

  • Lumentum Holdings (LITE) [MEDIUM RISK]

    The EVP of Global Reliability & Quality is retiring. While a consulting arrangement is in place, the departure of a senior quality executive could pose risks to product quality and reliability, a key competitive factor in the optical components industry.

  • Steven Madden (SHOO) [MEDIUM RISK]

    Adjusted operating expenses as a percentage of revenue increased to 39.8% from 37.9% YoY, indicating margin pressure despite strong revenue growth. This could be a sign of rising costs or investment spending that may not yield proportional returns.

  • Columbia Banking System (COLB) [LOW RISK]

    The appointment of a new director with over 40 years of experience is positive, but the banking sector faces headwinds from interest rate sensitivity and potential credit quality deterioration. The new director's risk management expertise is timely.

  • The adoption of amended bylaws with updated advance notice provisions for shareholder proposals could be seen as a defensive measure against activist investors, potentially limiting shareholder rights.

Opportunities (10)

  • MasTec (MTZ) (OPPORTUNITY)

    Record revenue and EPS growth, driven by the acquisition of The Superior Group, positions the company for continued outperformance in the infrastructure and energy sectors. The stock may be undervalued if the market focuses on the negative free cash flow rather than the growth trajectory.

  • PTC Therapeutics (PTCT) (OPPORTUNITY)

    The rapid ramp of Sephience (+21% QoQ) and raised full-year guidance suggest a potential blockbuster product. If the company can manage the decline of legacy products, the stock could see significant upside.

  • BrainStorm Cell Therapeutics (BCLI) (OPPORTUNITY)

    The appointment of a former FDA official as Executive Chairman is a strong signal of a strategic pivot to regulatory success. The Special Protocol Assessment for NurOwn is a unique catalyst that could lead to a significant re-rating if the Phase 3b trial is successful.

  • DXC Technology (DXC) (OPPORTUNITY)

    The new leadership appointments focused on AI and a streamlined structure could be the catalyst for a successful turnaround. The company's dual Core and Fast Track strategy may unlock value if execution improves.

  • Stride, Inc. (LRN) (OPPORTUNITY)

    The company reported solid revenue and earnings growth, and the CEO succession could bring a fresh perspective. The stock may be a value play if the market has not fully priced in the growth and stability of its online education model.

  • Cabot Corp (CBT) (OPPORTUNITY)

    The orderly CEO succession to an internal candidate (CFO) provides continuity and a clear strategic direction. The new CEO's deep knowledge of the business could lead to a smooth transition and continued operational improvements.

  • AAON, Inc. (AAON) (OPPORTUNITY)

    The appointment of two new independent directors with expertise in scaling operations and capital allocation is a positive signal for a company in a growth phase. This could lead to improved governance and strategic execution.

  • Vail Resorts (MTN) (OPPORTUNITY)

    The appointment of the CEO of MGM Resorts to the board brings deep hospitality and customer experience expertise, directly supporting the 'Epic Experience' initiative. This could drive higher guest spending and loyalty.

  • The appointment of Affirm's CFO to the board adds deep financial and fintech expertise. This could signal a strategic push into new payment or identity verification services, potentially expanding the company's TAM.

  • Crexendo, Inc. (CXDO) (OPPORTUNITY)

    The planned CTO succession to an internal candidate with nearly 20 years of experience ensures continuity in technology leadership. The company's platform serving nearly 8 million users provides a strong base for growth.

Sector Themes (6)

  • CEO Succession Planning in Industrials

    Cabot Corp and Green Brick Partners both announced planned CEO successions, promoting internal candidates (CFO and COO, respectively). This trend suggests a focus on continuity and deep institutional knowledge, which is generally viewed positively by the market. [IMPLICATION: Low disruption risk, potential for continued strategic execution]

  • Board Refreshment with Operational Expertise

    Multiple companies (Vail Resorts, Astec Industries, Clear Secure, AAON) appointed directors with deep operational and financial experience from large, successful companies (MGM, Atkore, Affirm). This signals a board-level focus on operational excellence, capital allocation, and scaling. [IMPLICATION: Improved governance and strategic oversight]

  • Mixed Earnings with Divergent Segment Performance

    Companies like MasTec and PTC Therapeutics reported strong headline numbers but showed significant weakness in specific segments (Communications at MasTec, legacy products at PTC). This highlights the importance of looking beyond aggregate figures to understand underlying business health. [IMPLICATION: Stock reactions may be binary, rewarding companies with broad-based strength]

  • Leadership Restructuring for AI and Digital Transformation

    DXC Technology and Henry Schein are restructuring their leadership teams to focus on AI and digital capabilities. This is a common theme across industries as companies seek to adapt to technological disruption. [IMPLICATION: High execution risk, but potential for significant value creation if successful]

  • Biotech Regulatory Catalyst Plays

    BrainStorm Cell Therapeutics' appointment of a former FDA official is a clear example of a biotech company building regulatory expertise at the board level to navigate a critical approval pathway. This is a high-risk, high-reward strategy. [IMPLICATION: Stock price will be highly sensitive to trial results and regulatory interactions]

  • Quiet Departures and Role Eliminations

    Sirius XM's elimination of the COO role and Cyngn's termination of its VP of Sales without a successor suggest cost-cutting or strategic shifts that may not be fully explained. These quiet departures can be a red flag for underlying business challenges. [IMPLICATION: Investors should scrutinize such filings for signs of deeper issues]

Watch List (8)

  • MasTec (MTZ)
    👁

    Watch for Q3 2026 earnings to see if free cash flow turns positive and if the Communications segment stabilizes. The integration of The Superior Group will be a key focus. [Next earnings: late Oct 2026]

  • PTC Therapeutics (PTCT)
    👁

    Monitor Sephience revenue growth trajectory and any updates on the competitive landscape for Translarna and Emflaza. The company's ability to manage the product transition is critical. [Next earnings: late Oct 2026]

  • BrainStorm Cell Therapeutics (BCLI)
    👁

    Watch for updates on the Phase 3b trial for NurOwn, including enrollment updates and any regulatory interactions. The new Executive Chairman's strategy will be closely watched. [No specific date]

  • Monitor the transition to the new CEO, Robert Knowling, and any strategic changes he may implement. The company's preliminary FY2026 results will be finalized, and guidance for FY2027 will be key. [Next earnings: late Oct 2026]

  • Watch for the announcement of a new CFO, which is expected by Q1 2027. The market will assess the new CFO's background and the company's capital allocation strategy going forward. [Target: Q1 2027]

  • Henry Schein (HSIC)
    👁

    Monitor the transition of the three executives to Senior Advisor roles and the effectiveness of the new Henry Schein Leadership Team. The company's Q3 2026 earnings will provide early insight into the restructuring's impact. [Next earnings: late Oct 2026]

  • Forrester Research (FORR)
    👁

    Watch for any further decline in contract value and whether the company's AI initiatives can reverse the revenue trend. The restarted buyback program is a positive signal, but sustained revenue growth is needed. [Next earnings: late Oct 2026]

  • DXC Technology (DXC)
    👁

    Monitor the execution of the new AI-centric strategy under the new leadership. The company's Q3 2026 earnings will be a key test of whether the restructuring is gaining traction. [Next earnings: late Oct 2026]

Filing Analyses (34)
Ceribell, Inc. 8-K neutral materiality 2/10

30-07-2026

Ceribell, Inc. announced a board restructuring effective July 28, 2026, reclassifying two existing directors (William W. Burke and Joseph M. Taylor) to different classes to achieve balanced board composition, and expanding the board from seven to nine members with the appointment of two new independent directors, Sharon L. O’Keefe and Thomas A. West. The new directors will receive standard non-employee director compensation, including an initial restricted stock unit award valued at $300,000 each. The changes are administrative in nature and do not involve any material financial impact or operational changes.

  • · Board increased from 7 to 9 directors.
  • · New directors O'Keefe and West appointed as Class I directors.
  • · O'Keefe appointed to Compensation Committee; West appointed to Audit Committee.
  • · Initial RSU award for each new director: $300,000, vesting one-third per year over three years.
  • · No material interest in any transaction requiring disclosure under Item 404(a) for either new director.
STEVEN MADDEN, LTD. 8-K positive materiality 8/10

30-07-2026

Steven Madden reported strong Q2 2026 results with revenue up 19.1% to $665.9M and net income of $27.7M vs a loss of $39.5M in Q2 2025. The company raised fiscal 2026 revenue guidance to 11-13% growth and adjusted diluted EPS to $2.05-$2.15. However, GAAP diluted EPS guidance remains at $2.55-$2.65, and adjusted operating expenses as a percentage of revenue increased to 39.8% from 37.9% in the prior year. The company also announced the appointment of Ken Pilot to the Board of Directors effective October 1, 2026.

  • · Adjusted gross profit margin improved to 46.5% from 41.9% in Q2 2025.
  • · Adjusted operating expenses as a percentage of revenue increased to 39.8% from 37.9% in Q2 2025.
  • · Wholesale revenue ex-Kurt Geiger grew 11.5%; DTC revenue ex-Kurt Geiger grew 11.1%.
  • · No share repurchases in Q2 2026.
  • · Quarterly dividend of $0.21 per share declared, payable September 24, 2026.
  • · Board expands from ten to eleven directors with Ken Pilot appointment effective October 1, 2026.
SIRIUS XM HOLDINGS INC. 8-K neutral materiality 4/10

30-07-2026

Sirius XM Holdings Inc. announced the departure of EVP and COO Wayne D. Thorsen, effective July 31, 2026, with no disagreements cited. The company will not appoint a successor COO. Thorsen will receive a $1.05M lump sum payment (prorated 2026 bonus) and forfeit all unvested equity awards.

  • · Departure effective July 31, 2026
  • · Separation agreement dated July 29, 2026
  • · Payment to be made within 60 days after separation, subject to release execution and non-revocation
  • · All unvested equity awards as of July 31, 2026 will be forfeited without consideration
  • · No successor COO will be appointed at this time
Flowco Holdings Inc. 8-K positive materiality 3/10

30-07-2026

Flowco Holdings Inc. (NYSE: FLOC) announced the appointment of John R. Rutherford as an independent director, effective July 29, 2026. This increases the board size to nine directors and the number of independent directors from four to five. Mr. Rutherford brings over 30 years of experience in energy and finance, including roles at Enterprise Products Partners, Plains All American Pipeline, and Lazard.

  • · Mr. Rutherford was appointed to the board of Enterprise GP, the general partner of Enterprise Products Partners L.P., and to the board of T.D. Williamson.
  • · He was appointed as a trustee of the Teacher Retirement System of Texas by Governor Greg Abbott in 2024.
  • · He previously served as Executive Vice President of Strategic Planning, M&A, and Business Development at Plains All American Pipeline.
  • · He spent over 20 years as an M&A advisor, including as Managing Director of Lazard's North American Energy Practice and a partner at Simmons & Company.
  • · He holds a BBA from The University of Texas at Austin and an MBA from the Wharton School.
HENRY SCHEIN INC 8-K neutral materiality 6/10

30-07-2026

Henry Schein announced a leadership restructuring, creating the Henry Schein Leadership Team (HSLT) to replace the Executive Management Committee, and integrating global supply chain with distribution. Three executives—Michael S. Ettinger (COO), Mark E. Mlotek (Chief Strategy Officer), and James Mullins (SVP Global Supply Chain)—will transition out of their roles effective October 30, 2026, and become Senior Advisors. The changes aim to simplify operations, accelerate decision-making, and enhance customer focus, but involve the departure of key long-tenured leaders.

  • · Three executives will become Senior Advisors effective October 31, 2026.
  • · The company had $13.2 billion in sales in 2025.
  • · Compound annual growth rate of approximately 11.0% since 1995.
  • · More than 25,000 employees and over 1 million customers globally.
  • · Selection of more than 300,000 branded and corporate brand products.
CABOT CORP 8-K positive materiality 7/10

30-07-2026

Cabot Corporation announced the planned retirement of President and CEO Sean Keohane, effective September 30, 2026, and the appointment of Erica McLaughlin, currently EVP, CFO and Head of Corporate Strategy, as his successor effective October 1, 2026. Keohane will remain in an advisory role through the end of 2026 to ensure a smooth transition. The company has also commenced a search for a new CFO. The leadership change is part of a deliberate succession plan and is expected to provide continuity, with no negative or flat financial metrics reported in this filing.

  • · Keohane will step down from the Board effective September 30, 2026.
  • · McLaughlin will serve on the Board as a member of the class of directors whose term expires at the 2029 Annual Meeting of Stockholders.
  • · McLaughlin has served as CFO since 2018 and previously held roles including Vice President, Business Operations for Reinforcement Materials and General Manager of its tire business, and Vice President of Investor Relations.
  • · McLaughlin currently serves on the Board of Directors of Azenta Life Sciences and on the Advisory Board of FM Global.
  • · Keohane has led the company since 2016, focusing the portfolio, strengthening core businesses, and advancing battery materials and sustainability.
Green Brick Partners, Inc. 8-K positive materiality 5/10

30-07-2026

Green Brick Partners announced the promotion of Jed Dolson from President and COO to Co-CEO, effective October 15, 2026, as part of its long-term succession planning. Mr. Dolson has been with the company since 2013 and has held increasingly senior roles, including President of Trophy Signature Homes during a critical growth period. The filing does not include any financial results or period-over-period comparisons, so no negative or flat metrics are present.

  • · Jed Dolson joined Green Brick Partners in 2013 as Head of Land Acquisition and Development.
  • · He served as President of the Texas Region, EVP and COO, and most recently as President of Green Brick Partners.
  • · From 2022-2024, he was President of Trophy Signature Homes, Green Brick's largest builder.
  • · Green Brick is the third largest homebuilder in Dallas-Fort Worth and operates in Texas, Georgia, and Florida.
  • · The company owns five subsidiary homebuilders in Texas and controlling interests in builders in Georgia and Florida.
FOSTER L B CO 8-K neutral materiality 3/10

30-07-2026

L.B. Foster Company announced executive officer changes effective August 1, 2026. Jason Bowlin is promoted to Senior Vice President – Rail, succeeding Greg Lippard, who will retire at the end of 2026. The changes are part of the company's focus on driving shareholder value and leveraging talent.

  • · Jason Bowlin, age 44, holds a Bachelor of Science in Mechanical Engineering from Georgia Institute of Technology.
  • · Gregory W. Lippard, age 58, has served the company since 1991 and will retire effective December 31, 2026.
  • · The company maintains locations in North America, South America, Europe, and Asia.
AAON, INC. 8-K positive materiality 5/10

30-07-2026

AAON, Inc. announced the appointment of Robert L. Buttermore III and Patrick J. Jermain as independent directors, effective July 28, 2026, increasing board size. The appointments bring expertise in enterprise-scale operations, global manufacturing, capital allocation, and governance as the company scales its HVAC and mission-critical cooling business. No financial metrics or period-over-period comparisons were provided in this filing.

  • · Mr. Buttermore will serve on the Compensation Committee.
  • · Mr. Jermain will serve on the Audit Committee.
  • · Mr. Buttermore holds a bachelor's degree in mechanical engineering from The Ohio State University.
  • · Mr. Jermain holds a bachelor's degree in accounting from Wake Forest University and an MBA from Northwestern University, Kellogg School of Management.
  • · AAON was founded in 1988 and is headquartered in Tulsa, Oklahoma.
LESAKA TECHNOLOGIES INC 8-K neutral materiality 4/10

30-07-2026

Lesaka Technologies, Inc. amended Executive Chairman Ali Mazanderani's employment agreement on July 30, 2026, extending its expiration to June 30, 2029, with all other terms unchanged. A new South African employment agreement with subsidiary Lesaka SA was also entered, effective July 1, 2026 through June 30, 2028 (extendable to 2029), with a ZAR 5,000,000 annual base salary and up to ZAR 4,000,000 in annual business travel costs. Mr. Mazanderani will work at 50% full-time equivalence and is not eligible for any short-term cash incentive or bonus programs under either agreement, and no severance benefits are provided.

  • · Mr. Mazanderani's US employment agreement was originally entered on December 4, 2023, effective February 1, 2024.
  • · Either party must provide three months advance notice to terminate the US agreement before June 30, 2029 in the absence of cause or material breach.
  • · The SA Employment Contract may be extended to June 30, 2029 by mutual written agreement.
  • · No short-term cash incentive or bonus eligibility under either agreement; no severance benefits provided.
FORRESTER RESEARCH, INC. 8-K mixed materiality 8/10

30-07-2026

Forrester Research reported Q2 2026 revenue of $100.2M, down 10.3% YoY from $111.7M, and GAAP net income of $15.3M ($0.78/diluted share) versus $3.9M ($0.20/diluted share) in Q2 2025. However, adjusted net income fell to $7.7M ($0.40/diluted share) from $9.8M ($0.51/diluted share), and contract value declined 3% YoY to $283.2M. The company maintained its full-year 2026 guidance, restarted its stock buyback program, and highlighted accelerated adoption of Forrester AI.

  • · All three revenue segments declined YoY: Research -8%, Consulting -14.7%, Events -17.2%.
  • · Client retention improved to 77% from 74% YoY; wallet retention improved to 89% from 85%.
  • · Number of clients fell slightly to 1,770 from 1,805.
  • · Total headcount reduced by 104 (7.1%) to 1,361; sales force reduced by 29 (5.4%) to 511.
  • · Full-year 2026 GAAP guidance includes an operating margin of -3.5% to -3.0% and diluted loss per share of $0.84 to $0.74.
  • · Adjusted full-year 2026 guidance: operating margin 6.0% to 6.5%, adjusted diluted EPS $0.72 to $0.82.
  • · Company incurred $2.1M in restructuring costs in Q2 2026 and $4.2M in H1 2026.
  • · Goodwill impairment of $10.8M recorded in H1 2026 (none in Q2 2026).
  • · Cash flow from operations was $25.0M in H1 2026 vs $23.1M in H1 2025.
  • · Capital expenditures surged to $18.2M in H1 2026 from $1.3M in H1 2025.
  • · Stock buyback program restarted with $0.96M in repurchases in H1 2026.
DORIAN LPG LTD. 8-K neutral materiality 3/10

30-07-2026

Dorian LPG Ltd. announced that its Board of Directors approved an Amended and Restated Executive Severance and Change in Control Severance Plan on July 24, 2026. The amendment revises the definition of 'Change in Control' by removing certain carve-outs that are no longer appropriate given the company's current shareholder base, aligning it with the definition in the company's equity incentive plan. No financial figures or performance metrics were disclosed in this filing.

  • · The Severance Plan was approved upon the recommendation of the company's compensation committee.
  • · The amendment removes certain carve-outs to the 'Change in Control' definition that are no longer appropriate in view of the company's current shareholders.
  • · The revised definition is intended to align with the definition in the company's Second Amended and Restated 2014 Equity Incentive Plan.
  • · The plan is effective July 24, 2026.
PTC THERAPEUTICS, INC. 8-K mixed materiality 9/10

30-07-2026

PTC Therapeutics reported strong Q2 2026 results with total revenue of $361 million, up from $179 million in Q2 2025, driven by Sephience product revenue of $151 million. The company raised full-year 2026 product revenue guidance to $850–$950 million. However, legacy products Translarna and Emflaza declined year-over-year, and the company reported a net income of $83.5 million versus a net loss of $64.8 million in the prior year. Hege Sollie-Zetlmayer was appointed to the Board of Directors.

  • · Sephience Q2 2026 revenue of $151.3 million represented 21% growth compared to Q1 2026.
  • · Translarna net product revenue declined 29.1% YoY to $42.2 million in Q2 2026 from $59.5 million in Q2 2025.
  • · Emflaza net product revenue declined 32.4% YoY to $24.6 million in Q2 2026 from $36.4 million in Q2 2025 due to continued generic erosion.
  • · GAAP R&D expenses decreased 12.2% YoY to $99.2 million in Q2 2026 from $113.0 million in Q2 2025.
  • · GAAP SG&A expenses decreased 5.4% YoY to $80.6 million in Q2 2026 from $85.3 million in Q2 2025.
  • · PTC issued $550.0 million of senior convertible notes due in 2031 at 0% coupon with a 40% conversion premium.
  • · Total debt stood at $590.97 million as of June 30, 2026, up from $286.63 million at December 31, 2025.
  • · Total stockholders' deficit was $165.36 million as of June 30, 2026, compared to $205.31 million at December 31, 2025.
  • · Shares issued and outstanding increased to 83,327,286 as of June 30, 2026, from 81,474,366 at December 31, 2025.
  • · Full-year 2026 GAAP R&D and SG&A expense guidance remains unchanged at $775 to $815 million.
Franklin BSP Capital Corp 8-K neutral materiality 2/10

30-07-2026

Franklin BSP Capital Corp appointed Kathleen Oates as Chief Accounting Officer (Principal Financial Officer and Principal Accounting Officer) effective July 27, 2026, replacing Nina Baryski who departed. Ms. Oates, 37, is an Executive Director at Benefit Street Partners and a CPA with prior experience at PwC. The filing contains no financial data or performance metrics.

  • · Ms. Oates joined BSP in 2020 and previously was a Senior Manager in the asset and wealth management assurance practice at PwC.
  • · She holds a Bachelor of Science in Finance and Accounting from Elon University and is a Certified Public Accountant.
  • · No family relationships or reportable transactions exist between Ms. Oates and the company's directors or officers.
  • · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.
Los Altos Ventures Corp. 8-K neutral materiality 3/10

30-07-2026

Matternet, Inc. (formerly Los Altos Ventures Corp.) appointed Sanjay Shah as a Class III director on July 28, 2026. Mr. Shah, a seasoned operations executive with leadership roles at Starbucks, GoPuff, Beyond Meat, Tesla, and Amazon, was granted a stock option to purchase 375,000 shares at $3.00 per share, vesting over four years. The filing contains no financial results or period-over-period comparisons, so no balanced performance metrics are available.

  • · Sanjay Shah, age 58, appointed as Class III director to serve until the 2029 annual meeting.
  • · Mr. Shah has served as EVP, Chief Supply Chain Officer of Starbucks since March 2025.
  • · Previous roles include SVP Operations at GoPuff (2021-2025), COO at Beyond Meat (2019-2021), SVP Energy Operations at Tesla (2018-2019), and various leadership roles at Amazon (2011-2018).
  • · Stock option grant vests in equal monthly amounts over four years, subject to continued service.
  • · Mr. Shah entered into the company's standard form of indemnification agreement.
  • · No arrangement or understanding exists between Mr. Shah and Matternet regarding his selection as director.
  • · No reportable transactions under Item 404(a) of Regulation S-K.
Fortune Brands Innovations, Inc. 8-K neutral materiality 3/10

30-07-2026

Fortune Brands Innovations, Inc. announced the departure of EVP, Chief Legal Officer and Corporate Secretary Hiranda S. Donoghue, effective July 31, 2026. Jack N. Melamed, VP, Deputy General Counsel and Assistant Secretary, will serve as interim Chief Legal Officer and Corporate Secretary. Ms. Donoghue's departure is not due to any disagreement with the company, and she will receive benefits under her existing agreement.

  • · Departure effective July 31, 2026.
  • · Ms. Donoghue's departure is a qualifying termination without cause under her Agreement for the Payment of Benefits Following Termination of Employment.
  • · Benefits eligibility is consistent with the Agreement described in the Definitive Proxy Statement filed March 30, 2026.
  • · No disagreement with the company regarding operations, policies, or practices.
ASTEC INDUSTRIES INC 8-K positive materiality 4/10

30-07-2026

Astec Industries appointed William E. Waltz, President and CEO of Atkore Inc., as an independent director effective October 29, 2026, increasing the board to 10 directors (nine independent). Waltz will serve on the Compensation Committee. The appointment adds public company CEO experience and a track record of driving organic and inorganic growth.

  • · Appointment effective October 29, 2026
  • · Waltz will serve on the Compensation Committee
  • · Waltz has been President and CEO of Atkore since 2018
  • · Prior roles include Chairman and CEO of Strategic Materials, Inc., and positions at Pentair, General Electric, and Deloitte
Clear Secure, Inc. 8-K neutral materiality 3/10

30-07-2026

Clear Secure, Inc. appointed Rob O'Hare, CFO of Affirm Holdings, to its Board of Directors and Audit Committee effective July 30, 2026, expanding the Board to ten members. Mr. O'Hare received an RSU grant valued at $480,000 vesting over three years and an annual cash retainer of $40,000. Concurrently, Tomago Collins rotated off the Audit Committee.

  • · Rob O'Hare has served as CFO of Affirm Holdings since November 2024, and previously as SVP, Finance at Affirm from August 2020.
  • · Mr. O'Hare holds a Bachelor's degree in Business Administration from Georgetown University.
  • · The RSU grant vests in three equal installments on each of the first three anniversaries of the grant date.
  • · No family relationships or material transactions exceeding $120,000 were identified involving Mr. O'Hare.
MASTEC INC 8-K mixed materiality 9/10

30-07-2026

MasTec reported record Q2 2026 results with revenue of $4.4B (+23% YoY), record adjusted diluted EPS of $2.22 (+49% YoY), and record adjusted EBITDA of $384M (+40% YoY). The company also closed the acquisition of The Superior Group, a premier electrical contractor. However, the Communications segment saw EBITDA decline 11.6% YoY to $73.1M with margin contraction of 170 bps, and free cash flow was negative at -$59M, worsening from -$45M in the prior year.

  • · Net debt increased to $2.42B as of June 30, 2026 from $1.93B at December 31, 2025.
  • · Cash and cash equivalents decreased to $315.6M from $396.0M at year-end 2025.
  • · Total assets grew to $10.93B from $9.92B at December 31, 2025.
  • · The company's effective tax rate for Q2 2026 was approximately 24.8%.
  • · Q3 2026 revenue guidance is $4.93B with adjusted EBITDA of $482M.
  • · Pipeline Infrastructure segment EBITDA margin improved 690 bps to 18.4%, the highest among segments.
  • · Communications segment EBITDA margin contracted 170 bps to 8.2%.
  • · Clean Energy and Infrastructure backlog grew 58% YoY to $7.79B.
  • · The Superior Group acquisition closed in July 2026, adding approximately 3,000 employees.
VAIL RESORTS INC 8-K positive materiality 5/10

30-07-2026

Vail Resorts appointed Bill Hornbuckle, CEO and President of MGM Resorts International, to its board of directors, effective July 30, 2026. Hornbuckle brings over 35 years of hospitality and resort operations experience, and his appointment aligns with Vail's 'Epic Experience' initiative to enhance guest journeys. The board now has ten members; no departures or negative metrics were disclosed.

  • · Hornbuckle has over 35 years of experience in hospitality, resort operations, marketing, and strategy.
  • · He played a key role in bringing the NHL's Golden Knights and NFL's Raiders to Las Vegas.
  • · Hornbuckle holds a bachelor's degree in Hotel Administration from the University of Nevada, Las Vegas.
  • · He currently serves as Chair of the U.S. Travel Association.
  • · Vail Resorts operates 37 ski resorts across North America, Switzerland, and Australia.
Lumentum Holdings Inc. 8-K neutral materiality 3/10

30-07-2026

Lumentum Holdings Inc. announced the planned retirement of Vincent Retort, Executive Vice President, Global Reliability & Quality, effective October 2026. Mr. Retort will provide consulting services for a two-year term, during which his outstanding equity awards will continue to vest. The filing does not include any financial results or period-over-period comparisons.

  • · Retirement effective date: October 2026
  • · Consulting term: two years following retirement
  • · Equity awards will continue to vest during consulting term per existing schedules
8X8 INC /DE/ 8-K neutral materiality 4/10

30-07-2026

8x8 Inc. appointed Colleen Martin-Garcia as principal accounting officer on July 29, 2026, succeeding Kevin Kraus who had been serving in that role. Ms. Martin-Garcia, age 56, brings experience from CareDx, Carbon, and Polycom, and will receive an annual base salary of $360,000 with a 50% target bonus. The Compensation Committee also approved a 600,000-share RSU award vesting over three years.

  • · Ms. Martin-Garcia joined the company on July 6, 2026, and was appointed principal accounting officer on July 29, 2026.
  • · Kevin Kraus's cessation as principal accounting officer was not due to any disagreement with the company.
  • · Ms. Martin-Garcia holds a Master of Science in Accountancy from San Jose State University and is a CPA in California (inactive).
  • · The RSU award will be granted in the ordinary course during the next quarterly grant cycle anticipated in September 2026.
  • · The RSUs vest one-third on the first anniversary and the remaining two-thirds quarterly over the subsequent eight quarters.
COASTAL FINANCIAL CORP 8-K neutral materiality 3/10

30-07-2026

Coastal Financial Corp (CCB) filed an 8-K on July 30, 2026, disclosing the adoption of Fourth Amended and Restated Bylaws (Items 5.03, 9.01) and a director/officer departure/election (Item 5.02). The amended bylaws update shareholder meeting procedures, including notice periods, quorum requirements, and advance notice provisions for shareholder proposals and director nominations. No financial figures were disclosed in this filing.

  • · Special meetings may be called by the CEO, President, any board member, or holders of at least one-third of voting shares.
  • · Shareholders may participate in meetings via conference telephone, video conference, or similar communications equipment.
  • · Action without a meeting requires a written consent resolution signed by shareholders holding at least the minimum votes necessary for approval at a meeting where all shares were present and voted.
  • · Advance notice for shareholder proposals must include detailed disclosures: description and text of proposal, shareholder and associated person info, share ownership, derivative positions, agreements, litigation, and a representation of continued shareholding through the meeting date.
  • · Director nominations by shareholders require timely written notice to the Secretary with similar detailed disclosures.
DXC Technology Co 8-K positive materiality 6/10

30-07-2026

DXC Technology announced leadership appointments to accelerate its AI-centric future, including Paul Taylor as President and Dan Gray as President of Global Infrastructure Services (GIS). Chris Drumgoole is departing as GIS President but will join the CEO Advisory Council. The moves aim to streamline operations and drive growth under the company's dual Core and Fast Track strategy, with a focus on AI-powered services.

  • · Paul Taylor brings over 30 years of technology and commercial leadership experience, including as a partner at IHS Markit through its sale to S&P Global.
  • · Dan Gray co-led the build and deployment of DXC OASIS from concept to production in just over a year.
  • · Chris Drumgoole will remain as a founding member of the CEO Advisory Council to advise Fernandez and the leadership team.
  • · Holly Grant was announced earlier this week as President, AI Innovation and Strategy & LabX.
Crexendo, Inc. 8-K positive materiality 5/10

30-07-2026

Crexendo, Inc. announced the planned succession of its Chief Technology Officer, with Chris Aaker appointed as CTO effective August 1, 2026, succeeding David Wang, who will remain full-time as Senior Vice President of Platform and Architecture. Aaker, previously SVP of Engineering, has nearly 20 years with the company and leads the engineering team for the NetSapiens platform serving nearly eight million users. The transition is part of a thoughtful leadership succession plan, with no negative or flat performance metrics reported.

  • · Chris Aaker holds a Bachelor of Science in Computer Engineering from San Diego State University and is a named inventor on a U.S. patent involving communications technology.
  • · Aaker is recognized as an authority in real-time communications, including SIP, voice, messaging, and cloud-based communications architecture.
  • · David Wang is one of the founders of NetSapiens and will continue full-time as Senior Vice President of Platform and Architecture.
BRAINSTORM CELL THERAPEUTICS INC. 8-K positive materiality 6/10

30-07-2026

BrainStorm Cell Therapeutics appointed former FDA Associate Commissioner Peter J. Pitts as Executive Chairman and Chief Strategic Regulatory and Policy Officer, effective July 28, 2026. Professor Jacob Frenkel transitions to Senior Advisor. The leadership change is aimed at advancing the Phase 3b trial for NurOwn® under the first Special Protocol Assessment ever granted for an ALS therapeutic candidate. The filing highlights a strategic shift to active daily executive leadership but does not provide any financial metrics or performance data.

  • · NurOwn® has received Orphan Drug designation from both the U.S. FDA and the European Medicines Agency.
  • · A Phase 3 trial in ALS has been completed.
  • · The SPA is the first ever granted for an ALS therapeutic candidate.
  • · Professor Frenkel has been with BrainStorm since 2007 and served as Board Chairman since 2020.
Oric Pharmaceuticals, Inc. 8-K neutral materiality 3/10

30-07-2026

ORIC Pharmaceuticals, Inc. announced that its Board of Directors approved an amendment to the 2022 Inducement Equity Incentive Plan, increasing the number of shares reserved for issuance by 1,100,000 shares to a total of 3,350,000 shares. The plan is used to grant equity awards as inducements for new employees and, where permitted, in connection with mergers or acquisitions, and was adopted without stockholder approval under Nasdaq rules. No financial results or performance metrics were disclosed in this filing.

  • · The Inducement Plan is substantially similar to the Company’s 2020 Equity Incentive Plan, including treatment of awards in a merger or change in control.
  • · Awards under the Inducement Plan are limited to individuals not previously employees or non-employee directors, or following a bona fide period of non-employment, as an inducement to employment.
  • · The amendment was adopted without stockholder approval pursuant to applicable Nasdaq Listing Rules.
BEYOND MEAT, INC. 8-K neutral materiality 5/10

30-07-2026

Beyond Meat appointed Brijesh Krishnaswamy as Chief Operating Officer, effective part-time from August 24, 2026, and full-time from September 30, 2026, with a base salary of $110,000 per year during part-time employment increasing to $550,000 per year upon full-time conversion. Additionally, the board appointed founder and CEO Ethan Brown as a Class III director, filling a vacancy. The filing does not include any financial results or performance metrics, so no period-over-period comparisons are available.

  • · Brijesh Krishnaswamy, age 52, previously served as Chief Commercial Officer – North America at ofi since February 2025, and held various leadership roles at ofi since 2000.
  • · Krishnaswamy holds a BBA from Bhopal School of Social Sciences, an MBA from Symbiosis Institute of Business Management, and completed the Advanced Management Program at Wharton.
  • · Upon Krishnaswamy's full-time start, John Boken will cease performing the duties of Chief Operations Officer.
  • · Ethan Brown, age 55, previously served on the board from inception until October 15, 2025, and is being reappointed to fill the vacancy left by Raphael Thomas Wallander's resignation on May 28, 2026.
  • · Brown is a Henry Crown Fellow at the Aspen Institute and recipient of the UN Champion of the Earth award (2018).
Cyngn Inc. 8-K negative materiality 3/10

30-07-2026

Cyngn Inc. terminated Martin Petraitis, Vice President of Sales and a named executive officer, effective July 24, 2026. The company thanked him for his contributions and wished him well. No financial details or successor were disclosed.

  • · Termination effective July 24, 2026.
  • · Filing date: July 30, 2026.
  • · No successor or interim replacement announced.
COLUMBIA BANKING SYSTEM, INC. 8-K positive materiality 3/10

30-07-2026

Columbia Banking System, Inc. appointed Simone Lagomarsino to its Board of Directors, effective September 1, 2026. Lagomarsino brings over 40 years of financial services experience and will serve on the Enterprise Risk Management and Audit Committees. The appointment is part of Columbia's efforts to strengthen its franchise and deliver long-term shareholder value.

  • · Simone Lagomarsino appointed to Board effective September 1, 2026.
  • · She will serve on Enterprise Risk Management Committee and Audit Committee.
  • · Lagomarsino has over 40 years of leadership experience in finance, governance, and risk management.
  • · Most recently served as President and Chief Risk Officer of First Foundation Inc. and First Foundation Bank until its sale.
  • · Previously served as President and CEO of Luther Burbank Corporation and Luther Burbank Savings, leading it until its sale.
  • · Also served as President and CEO of California Bankers Association and CEO of Heritage Oaks Bancorp.
  • · Prior board service includes First Foundation Inc., Federal Home Loan Bank of San Francisco, Luther Burbank Corporation, Hannon Armstrong, Pacific Premier Bancorp, and Heritage Oaks Bancorp.
  • · Served on the board of the Federal Reserve Bank of San Francisco.
  • · Named 'Community Banker of the Year' by American Banker and 'Banking & Finance Visionary' by Los Angeles Times.
  • · Earned BA in Economics from Claremont McKenna College and MBA in Finance from Claremont Graduate School.
Stride, Inc. 8-K mixed materiality 8/10

30-07-2026

Stride, Inc. reported preliminary FY2026 results with revenue of $2,518.1M (up 4.7% YoY from $2,405.3M) and net income of $338.2M (up 17.5% from $287.9M). However, adjusted operating income growth was more modest at 6.9% ($498.4M vs $466.2M), and adjusted EBITDA grew 8.2% to $617.6M. The company also announced a CEO succession: Robert Knowling, an independent board member, was appointed CEO effective July 29, 2026, replacing James Rhyu. Steven Fink was named Chair of the Board, and Brian Shepherd was appointed to the Board.

  • · Robert Knowling has served on the Board for more than eight years.
  • · James Rhyu served as CEO for the last five years and over 13 years total at Stride.
  • · Brian Shepherd was appointed to the Board effective July 29, 2026, and will serve on the Compensation Committee and Audit Committee.
  • · Stride will report full financial results and file Form 10-K on August 4, 2026.
  • · The company serves learners in all 50 states and over 100 countries.
TENNANT CO 8-K neutral materiality 6/10

30-07-2026

Tennant Company (NYSE: TNC) announced the planned retirement of CFO Fay West, who will step down after a successor is hired and an appropriate transition period, expected in Q2 2027 but no earlier than April 2, 2027. The company has initiated a search for a new CFO, aiming to name a replacement by Q1 2027. While the departure of a key financial leader introduces leadership transition risk, the company highlighted Ms. West's significant contributions to growth strategy, capital allocation, and M&A during her tenure since 2021.

  • · Ms. West joined the company in 2021 and has served as CFO for five years.
  • · The company is targeting a replacement by Q1 2027 to allow a transition period before Ms. West's departure.
  • · Tennant Company had sales of $1.20 billion in 2025 and approximately 4,500 employees.
  • · The company operates manufacturing worldwide, sells directly in over 25 countries, and through distributors in over 100 countries.
OLD DOMINION ELECTRIC COOPERATIVE 8-K neutral materiality 2/10

30-07-2026

Old Dominion Electric Cooperative announced the election of Tobias B. Moss to its board of directors, effective July 28, 2026, replacing Belvin Williamson, Jr. Mr. Moss was recommended by A&N Electric Cooperative. The filing contains no financial data or performance metrics.

LEE ENTERPRISES, Inc 8-K neutral materiality 2/10

30-07-2026

Herbert W. Moloney III retired from the Board of Directors of Lee Enterprises, Incorporated effective July 28, 2026. The departure is not due to any disagreements with the company. No financial figures or performance metrics were disclosed in this filing.

  • · Herbert W. Moloney III retired from the Board effective July 28, 2026.
  • · The retirement is not due to any disagreements with the company.

Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 34 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Corporate Board Director Changes SEC Filings

🇺🇸 More from United States

View all →